{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:56:08Z","timestamp":1792252568578,"version":"4.4.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,29]],"date-time":"2014-08-29T00:00:00Z","timestamp":1409270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.ijid.2014.07.007","type":"journal-article","created":{"date-parts":[[2014,9,18]],"date-time":"2014-09-18T12:34:01Z","timestamp":1411043641000},"page":"80-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Salvage combination antifungal therapy for acute invasive aspergillosis may improve outcomes: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"28","author":[{"given":"Anil A.","family":"Panackal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Parisini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Proschan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2014.07.007_bib0005","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jinf.2012.08.003","article-title":"Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry","volume":"65","author":"Steinbach","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2014.07.007_bib0010","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2014.07.007_bib0015","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.ijid.2014.07.007_bib0020","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1086\/317487","article-title":"Burden of aspergillosis-related hospitalizations in the United States","volume":"31","author":"Dasbach","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2014.07.007_bib0025","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.2146\/ajhp080325","article-title":"Mortality, length of hospitalization, and costs associated with invasive fungal infections in high-risk patients","volume":"66","author":"Menzin","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ijid.2014.07.007_bib0030","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1086\/376634","article-title":"Amphotericin B: time for a new \u2018gold standard\u2019","volume":"37","author":"Ostrosky-Zeichner","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2014.07.007_bib0035","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2014.07.007_bib0040","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1086\/497126","article-title":"Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome","volume":"41","author":"Patterson","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2014.07.007_bib0045","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1086\/423381","article-title":"Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy","volume":"39","author":"Maertens","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2014.07.007_bib0050","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/1471-2334-10-182","article-title":"Caspofungin use in daily clinical practice for treatment of invasive aspergillosis: results of a prospective observational registry","volume":"10","author":"Maertens","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2014.07.007_bib0055","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/bmt.2009.334","article-title":"Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: a European Organisation for Research and Treatment of Cancer study","volume":"45","author":"Herbrecht","year":"2010","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.ijid.2014.07.007_bib0060","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1128\/AAC.46.8.2564-2568.2002","article-title":"Efficacy of caspofungin alone and in combination with voriconazole in a guinea pig model of invasive aspergillosis","volume":"46","author":"Kirkpatrick","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2014.07.007_bib0065","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/jac\/dkp175","article-title":"Combination therapy with micafungin and amphotericin B for invasive pulmonary aspergillosis in an immunocompromised mouse model","volume":"64","author":"Nagasaki","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2014.07.007_bib0070","series-title":"A randomised, double-blind study of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis","author":"Marr","year":"2012"},{"key":"10.1016\/j.ijid.2014.07.007_bib0075","first-page":"713","article-title":"A randomised, double-blind study of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis","volume":"18","author":"Marr","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2014.07.007_bib0080","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/514341","article-title":"Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)","volume":"44","author":"Cornely","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2014.07.007_bib0085","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/cncr.23311","article-title":"Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy","volume":"112","author":"Hachem","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ijid.2014.07.007_bib0090","first-page":"635","article-title":"Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis","volume":"24","author":"White","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2014.07.007_bib0095","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1002\/cncr.22348","article-title":"Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis","volume":"107","author":"Maertens","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ijid.2014.07.007_bib0100","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2014.07.007_bib0105","series-title":"Systematic reviews in health care: meta-analysis in context","author":"Egger","year":"2007"},{"key":"10.1016\/j.ijid.2014.07.007_bib0110","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2014.07.007_bib0115","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus","volume":"34","author":"Ascioglu","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2014.07.007_bib0120","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2014.07.007_bib0125","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/cncr.23441","article-title":"Changes in causes of death over time after treatment for invasive aspergillosis","volume":"112","author":"Wingard","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ijid.2014.07.007_bib0130","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1086\/590566","article-title":"Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria","volume":"47","author":"Segal","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2014.07.007_bib0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ijid.2014.07.007_bib0140","series-title":"The Newcastle\u2013Ottawa scale NOS) for assessing the quality of nonrandomised studies in metaanalyses","author":"Wells","year":"2010"},{"key":"10.1016\/j.ijid.2014.07.007_bib0145","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ijid.2014.07.007_bib0150","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ijid.2014.07.007_bib0155","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.0006-341X.1999.00732.x","article-title":"Valid inference in random effects meta-analysis","volume":"55","author":"Follmann","year":"1999","journal-title":"Biometrics"},{"key":"10.1016\/j.ijid.2014.07.007_bib0160","series-title":"Modern epidemiology","author":"Rothman","year":"1998"},{"key":"10.1016\/j.ijid.2014.07.007_bib0165","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","article-title":"Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis","volume":"54","author":"Sterne","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ijid.2014.07.007_bib0170","series-title":"Combination antifungals for primary treatment of invasive aspergillosis (IA): do they work? Abstract M-1024","author":"Munoz","year":"2004"},{"key":"10.1016\/j.ijid.2014.07.007_bib0175","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1086\/421950","article-title":"Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases","volume":"39","author":"Steinbach","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2014.07.007_bib0180","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1086\/423380","article-title":"Combination antifungal therapy for invasive aspergillosis","volume":"39","author":"Marr","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2014.07.007_bib0185","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1016\/j.transproceed.2005.09.182","article-title":"Invasive pulmonary aspergillosis in solid organ and bone marrow transplant recipients","volume":"37","author":"Trullas","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ijid.2014.07.007_bib0190","first-page":"149","article-title":"Treatment of invasive fungal infections with voriconazole. Evaluation of experience with compassionate use of voriconazole in Spain","volume":"18","author":"D\u00edaz Pedroche","year":"2005","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.ijid.2014.07.007_bib0195","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/01.tp.0000202421.94822.f7","article-title":"Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study","volume":"81","author":"Singh","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.ijid.2014.07.007_bib0200","series-title":"Combination antifungal therapy as primary therapy for invasive aspergillosis","author":"Waala","year":"2009"},{"key":"10.1016\/j.ijid.2014.07.007_bib0205","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3324\/haematol.2009.012054","article-title":"Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study","volume":"95","author":"Pagano","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.ijid.2014.07.007_bib0210","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1002\/cncr.25312","article-title":"Does combination of lipid formulation of amphotericin B and echinocandins improve outcome of invasive aspergillosis in hematological malignancy patients?","volume":"116","author":"Mihu","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ijid.2014.07.007_bib0215","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s15010-011-0108-6","article-title":"The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis","volume":"39","author":"Schwartz","year":"2011","journal-title":"Infection"},{"key":"10.1016\/j.ijid.2014.07.007_bib0220","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/j.1469-0691.2011.03548.x","article-title":"Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005\u20132007)","volume":"17","author":"Lortholary","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2014.07.007_bib0225","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s10096-011-1425-5","article-title":"An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazole","volume":"31","author":"Jacobs","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2014.07.007_bib0230","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.ijid.2012.09.004","article-title":"Invasive aspergillosis in patients with hematological malignancies in the Czech and Slovak republics: Fungal InfectioN Database (FIND) analysis, 2005\u20132009","volume":"17","author":"Racil","year":"2013","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2014.07.007_bib0235","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3109\/13693786.2012.690108","article-title":"Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis","volume":"51","author":"Baddley","year":"2013","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijid.2014.07.007_bib0240","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/cncr.23109","article-title":"Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: a randomized pilot study (Combistrat trial)","volume":"110","author":"Caillot","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ijid.2014.07.007_bib0245","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/13693780701278386","article-title":"Clinical efficacy of micafungin for chronic pulmonary aspergillosis","volume":"45","author":"Izumikawa","year":"2007","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijid.2014.07.007_bib0250","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1399-3062.2008.00349.x","article-title":"Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis: short communication","volume":"11","author":"Kontoyiannis","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijid.2014.07.007_bib0255","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00101-010-1795-6","article-title":"[Caspofungin after solid organ transplantation in Germany: observational study on treatment of invasive fungal infections]","volume":"59","author":"Lichtenstern","year":"2010","journal-title":"Der Anaesthesist"},{"key":"10.1016\/j.ijid.2014.07.007_bib0260","first-page":"1","article-title":"Caspofungin use in daily clinical practice for treatment of invasive aspergillosis: results of a prospective observational registry","volume":"10","author":"Maertens","year":"2009","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2014.07.007_bib0265","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1399-3062.2009.00490.x","article-title":"Caspofungin for post solid organ transplant invasive fungal disease: results of a retrospective observational study","volume":"12","author":"Winkler","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijid.2014.07.007_bib0270","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2047-783X-17-7","article-title":"Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registry","volume":"17","author":"Egerer","year":"2012","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.ijid.2014.07.007_bib0275","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jinf.2006.03.003","article-title":"Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis","volume":"53","author":"Denning","year":"2006","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2014.07.007_bib0280","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3109\/13693786.2012.693213","article-title":"Caspofungin for the treatment of invasive fungal disease in hematological patients (ProCAS Study)","volume":"51","author":"Jarque","year":"2013","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijid.2014.07.007_bib0285","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/cncr.11479","article-title":"Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies","volume":"98","author":"Kontoyiannis","year":"2003","journal-title":"Cancer"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971214015926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971214015926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T13:20:52Z","timestamp":1538227252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971214015926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":57,"alternative-id":["S1201971214015926"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2014.07.007","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salvage combination antifungal therapy for acute invasive aspergillosis may improve outcomes: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2014.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}